Case Page

 

Case Status:    DISMISSED    
On or around 09/25/2000 (Other)

Filing Date: January 05, 1999

According to the Form 10-Q for the quarterly period ended September 30, 2000, the Company's motion to dismiss the federal securities case was granted on December 22, 1999. The decision was affirmed on appeal.

According to the same 10-Q filing, the class-action was filed in connection with the Federal Trade Commission's 1998 lawsuit, alleging the Company engaged
in restraint of trade, monopolization, attempted monopolization and conspiracy
to monopolize arising out of certain agreements involving the supply of raw
materials used to manufacture two drugs.

The Complaint asserts claims under the federal securities laws, including claims for violation of Section 10(b) and 20 (a) of the Securities Exchange Act of 1934 and Rule 10b-5 of the Securities Exchange Commission, by reason of issuance of certain material facts and omissions in statements concerning Mylan business practices, earnings and profitability that were contained in public press releases and filings with the SEC rendering these statements false and misleading. As a result of these false and misleading statements, the market price of Mylan common stock was artificially inflated during the Class Period.

COMPANY INFORMATION:

Sector: Healthcare
Industry: Biotechnology & Drugs
Headquarters: United States

SECURITIES INFORMATION:

Ticker Symbol: MYL
Company Market: New York SE
Market Status: Public (Listed)

About the Company & Securities Data


"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
COURT: W.D. Pennsylvania
DOCKET #: 99-CV-00010
JUDGE: Hon. Robert J. Cindrich
DATE FILED: 01/05/1999
CLASS PERIOD START: 02/17/1998
CLASS PERIOD END: 12/05/1998
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. Kirby McInerney & Squire LLP
    830 Third Avenue 10th Floor, Kirby McInerney & Squire LLP, NY 10022
    212.317.2300 ·
No Document Title Filing Date